About this trial
The objective of this questionnaire study is to evaluate the concordance between the information provided to parents during antenatal consultations and their subsequent experiences following childbirth.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients were observed at the multidisciplinary prenatal diagnosis centre.
Patients who had attended at least one antenatal consultation with a pediatric neonatologist
Patients who gave birth between January 2020 and December 2022 and whose newborn was hospitalized in the neonatology department
Disqualifiers
a child who died in hospital or had a condition with a high risk of death in the first few years of life
non-French speaking mothers
Mothers who were minors at the time of the study
Trial population
Of the patients who were followed up at the multidisciplinary prenatal diagnosis centre and had an antenatal consultation with a pediatric neonatologist, 113 patients met the inclusion criteria.
Trial design
Other
Retrospective
Treatments tested in this trial
Survey
Other interventionThe study utilised a 16-item questionnaire to evaluate the quality of information received during antenatal diagnosis consultations and its congruence with subsequent experiences following birth and hospitalisation of the infant. The questionnaire encompassed seven questions pertaining to consultation arrangements, including duration, frequency and unit visits, six questions addressing the received information, and three questions exploring the long-term outcomes of the child.
Treatment groups
Trial outcomes
Primary outcomes
Question 8 of the questionnaire
In summary, did the information provided during the consultation with the paediatrician correspond to the events that transpired during your child's hospitalisation ? Patients are invited to indicate their level of agreement or disagreement with a series of four statements by selecting one of four options : 'not at all', 'to some extent', 'almost' or 'completely'.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.